  | 
   
  
    
        
          |   | 
          
              
                | 
                    º¹ÇÕÄ«µ¦½Åݼ¿  CADEXIN COMP CAPS.[Cyanocobalamin , Diclofenac sodium , Pyridoxine HCl , Thiamine nitrate]  
                    
                 | 
               
              
                | 
                     Àü¹®ÀǾàǰ | »èÁ¦  
                        
                    	
                    
                 | 
               
              
                | 
					  
                  
				  
                 | 
               
              
              
              
              
              |   |  
              
                
                    
                        | 
                      ¾Ë¸²:  | 
                      µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. | 
                     
                    | 
               
            
              
                
                   
                   
                   
                   
		   
                 | 
               
              
                | 
                  
                  
                 | 
               
              | 
            | 
         
       
       | 
   
    |  
  
    | 
      
     | 
     
  |                   
                                        | 
                                             | 
                                         
                            
                                
                            
                            
                              
                                                        
                              
                                                
                            
 |   
    | 
      
     | 
 
 |  
    
   
    | 
       
        À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
        ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
        À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
        ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
       
     | 
   
  
     | 
   
  
  
    
      
  
    
       |  
      
        
          
            
                | Çã°¡Á¤º¸ | 
             
           
         | 
       
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
  
  
  
   
    û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå  »óÇÑ±Ý¾× | 
    
      
      
        
        660700650[A03701471]  
	    
	    
            [º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸] 
          
        
        
        
          
          
            \0 ¿ø/1ĸ½¶(2007.11.15)(ÇöÀç¾à°¡)
            \58 ¿ø/1ĸ½¶(2006.03.01)(º¯°æÀü¾à°¡)
        
          
            
	 
  	   
  	   
       
      
       
       
     
      
      
     
      
    
    
    
      
     [»óº´ÄÚµåÁ¶È¸]
      
      [Áúº´ÄÚµåÁ¶È¸]
     
     | 
   
   
    | ºü¸¥Á¶È¸ | 
    
      
     |   
   
  
  
  
   
    | Á¦Ç°¼º»ó | 
    ¿¬ºÐÈ«»ö °ú¸³»ó ºÐ¸»°ú ¹é»öÀÇ Àå¿ë¼º °ú¸³ÀÌ µé¾îÀÖ´Â »ó-ÃÝÄÚ·¿»ö, ÇÏ-º£ÀÌÁö»ö ݼ¿Á¦  [Á¦ÇüÁ¤º¸ È®ÀÎ] |   
   
  
  
  
  
  
   
    | Æ÷À塤À¯Åë´ÜÀ§ | 
    100CAPS | 
   
  
  
  
  
  
  
  
 
  
  
    
  
  
  
  
  
  
  
  
  
  
 
  
  
  
 
  
  
  
  
  
  
   
    | Çã°¡»çÇ× ¿ø¹®Á¶È¸ | 
    
      
	    [Çã°¡»çÇ× ¿ø¹®Á¶È¸] 
     | 
   
  
  
  
  
     
  
  
  
   
    | È¿´ÉÈ¿°ú | 
    
    [ÀûÀÀÁõ º° °Ë»ö] 
      
    
     
	 
      
1.ÁÖ È¿´É È¿°ú  
  ·ù¸¶Æ¼¾ç °üÀý¿°,°ñ°üÀý¿°(ÅðÇ༺ °üÀýÁúȯ)  
  2.´ÙÀ½ Áúȯ¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Ù.  
  ¼ö¼úÈÄ ¿°Áõ ¹× µ¿Åë,¿äÅë,Ä¡Åë
      
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
    
  
  
  
  
  
   
    | ¿ë¹ý¿ë·® | 
    
      * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù. 
    
     
      
      
      [󹿾à¾î] 
      [ÁÖ¼ººÐÄÚµå:254400ACH ¿¡ µû¸¥ ½É»çÁöħ¿¶÷] 
¼ºÀÎ 1ȸ 1ݼ¿ 1ÀÏ 3ȸ °øº¹½Ã¸¦ ÇÇÇÏ¿© º¹¿ëÇÑ´Ù. 
      
      	
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
    | ±Ý±â | 
    1) ¼Òȼº±Ë¾ç ȯÀÚ  
2) ½ÉÇÑ Ç÷¾×ÀÌ»ó ȯÀÚ  
3) ½ÉÇÑ °£Àå¾Ö ȯÀÚ  
4) ½ÉÇÑ ½ÅÀå¾Ö ȯÀÚ  
5) ½ÉÇÑ °íÇ÷¾Ð ȯÀÚ  
6) ½ÉÇÑ ½É±â´ÉºÎÀü ȯÀÚ  
7) ÀÌ ¾àÀÇ ¼ººÐ¿¡ °ú¹ÎÁõÀÌ Àִ ȯÀÚ  
8) ÀÌ ¾àÀ̳ª ¾Æ½ºÇǸ° µî ´Ù¸¥ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦(COX-2 ÀúÇØÁ¦ Æ÷ÇÔ)¿¡ ÀÇÇÏ¿© õ½Ä, µÎµå·¯±â ¶Ç´Â ´Ù¸¥ ¾Ë·¹¸£±â ¹ÝÀÀ º´·ÂÀÌ Àִ ȯÀÚ(ÀÌ·¯ÇÑ È¯ÀÚ¿¡¼ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦ Åõ¿©ÈÄ Ä¡¸íÀûÀÎ ÁßÁõÀÇ ¾Æ³ªÇʶô½Ã¾ç ¹ÝÀÀÀÌ µå¹°°Ô º¸°íµÇ¾ú´Ù.)  
9) °ü»óµ¿¸Æ ¿ìȸ·Î¼ú(CABG) ÀüÈÄ¿¡¹ß»ýÇÏ´Â ÅëÁõÀÇ Ä¡·á  
 
 | 
   
  
  
  
  
   
    | ½ÅÁßÅõ¿© | 
    1) ¼Òȼº±Ë¾çÀÇ º´·ÂÀÌ Àִ ȯÀÚ  
2) Ç÷¾×ÀÌ»ó ¶Ç´Â ±× º´·ÂÀÌ Àִ ȯÀÚ  
3) °£Àå¾Ö, ½ÅÀå¾Ö ¹× ±× º´·ÂÀÌ Àִ ȯÀÚ  
4) °íÇ÷¾Ð ȯÀÚ  
5) ½É±â´ÉºÎÀü ȯÀÚ  
6) SLE(Àü½Å¼º È«¹Ý¼º ·çǪ½º) ȯÀÚ  
7) °ú¹ÎÁõÀÇ º´·ÂÀÌ Àִ ȯÀÚ  
8) ±â°üÁöõ½Ä ȯÀÚ  
9) ±Ë¾ç¼º´ëÀå¿° ȯÀÚ  
10) Å©·Ðº´ ȯÀÚ  
11) ½ÄµµÅë°úÀå¾Ö ȯÀÚ  
12) °í·ÉÀÚ, ¾î¸°ÀÌ, À¯¼Ò¾Æ  
 
 | 
   
  
    
  
  
  
  
  
   
    | ÀÌ»ó¹ÝÀÀ | 
    
      1) ¼ï : µå¹°°Ô ¼ïÁõ»ó(Èä³»°í¹Î, ³ÃÇÑ, È£Èí°ï¶õ, »çÁö¸¶ºñ°¨, Ç÷¾ÐÀúÇÏ, ºÎÁ¾, ¹ßÁø, °¡·Á¿òÁõ µî)À̳ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ °æ¿ì¿¡´Â Åõ¿©¸¦ ÁßÁöÇϰí ÀûÀýÇÑ Á¶Ä¡¸¦ ÇÑ´Ù.  
2) ¼Òȱâ°è : µå¹°°Ô ¼Òȼº±Ë¾ç, À§ÀåÃâÇ÷, ½Äµµ±Ë¾çÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ °æ¿ì¿¡´Â Åõ¿©¸¦ ÁßÁöÇÑ´Ù. ¶§¶§·Î ½Ä¿åºÎÁø, ±¸¿ª, ±¸Åä, À§Åë, ¼ÒȺҷ®, °íÀå, Èæº¯, ¾ÆÇÁŸ¼º ±¸³»¿°, ±¸°°ÇÁ¶, Á¡¸·°ÇÁ¶, Ç÷¾×¼º ¼³»ç, ½Ä¿åº¯È, ÃéÀå¿°, ´ëÀå¿°, ¼³»çµå¹°°Ô ±¸³»¿°, ±¸°¥, º¯ºñ, ÇϺÎÀå°ü Àå¾Ö(ºñƯÀ̼º ´ëÀå¿°, Å©·Ðº´¶Ç´Â ±Ë¾ç¼º ´ëÀå¿°ÀÇ ¾ÇÈ) µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
3) Ç÷¾× : µå¹°°Ô °ú¸³±¸ °¨¼Ò, Çì¸ð±Û·Îºó °¨¼Ò, ¹éÇ÷±¸ °¨¼Ò, Ç÷¼ÒÆÇ°¨¼Ò, ºóÇ÷, Àç»ýºÒ·®¼º ºóÇ÷, ¿ëÇ÷¼º ºóÇ÷, ÃâÇ÷°æÇâ, ÀÚ¹Ý, ¾Ë·¹¸£±â¼º ÀÚ¹Ý µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
4) ÇǺΠ: µå¹°°Ô ½ºÆ¼ºì½¼-Á¸½¼ÁõÈıº(ÇǺÎÁ¡¸·¾ÈÁõÈıº), ¸®¿¤ÁõÈıº(Áßµ¶¼ºÇ¥ÇDZ«»çÁõ), ±¤°ú¹ÎÁõ, ¹ßÀû, °¡·Á¿òÁõ, ½ÀÁø, ÇǺο°, Ç÷°üºÎÁ¾, ´ÙÇü¼ºÈ«¹Ý, È«Á¶, »ïÃ⼺ ÇǺο°ÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ °æ¿ì¿¡´ÂÅõ¿©¸¦ ÁßÁöÇϰí ÀûÀýÇÑ Á¶Ä¡¸¦ ÇÑ´Ù.  
5) °£Àå : µå¹°°Ô °£¿°, Ȳ´Þ, °£Àå¾Ö, GOT, GPT »ó½ÂÀ̳ªÅ¸³¯ ¼ö ÀÖ´Ù. ƯÈ÷ ±ÝÁ¦Á¦¿Í º´¿ëÅõ¿©½Ã ÁÖÀÇÇÑ´Ù.  
6) ½ÅÀå : µå¹°°Ô ±Þ¼º ½ÅºÎÀü, ³×ÇÁ·ÎÁ¦ÁõÈıºÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ÇÌ´¢, Ç÷´¢, ¿ä´Ü¹é, BUN, Ç÷Áß Å©·¹¾ÆÆ¼´Ñ »ó½Â, °íÄ®·ýÇ÷Áõ, Àú¾ËºÎ¹ÎÇ÷Áõ µîÀÌ ³ªÅ¸³ª´Â °æ¿ì¿¡´Â Áï½Ã Åõ¿©¸¦ ÁßÁöÇϰíÀûÀýÇÑ Á¶Ä¡¸¦ ÇÑ´Ù.  
7) °ú¹ÎÁõ : µå¹°°Ô õ½Ä¹ßÀÛ ¶§¶§·Î ¹ßÁø, µÎµå·¯±â µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ °æ¿ì¿¡´Â Åõ¿©¸¦ ÁßÁöÇϰí ÀûÀýÇÑ Á¶Ä¡¸¦ ÇÑ´Ù.  
8) Á¤½Å½Å°æ°è : ºÒ¸é, ¿ì¿ï, ÀÚ±Ø °ú¹Î¼º, ºÒ¾È, º¹½Ã°¡ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. µå¹°°Ô µÎÅë, Á¹À½, Çö±â, ½Å°æ°ú¹Î, ¸¶ºñ, Âø¶õ, ȯ°¢, °æ·Ã µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
9) °¨°¢±â°è : µå¹°°Ô ½Ã¾ßȥŹ, À̸í, Àϰú¼ºÀÇ µ¿Åë, °ÇÁ¶°¨, °¡·Á¿òÁõ, Ç¥Ãþ°¢¸·¿° µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
10) ¼øÈ¯±â°è : µå¹°°Ô Ç÷¾Ð»ó½Â, Ç÷¾ÐÀúÇÏ, ½É°èÇ×Áø, ºó¸Æ, ¿ïÇ÷¼º½ÉºÎÀü, ½É½Ç¼º ±â¿Ü¼öÃà, ½É±Ù°æ»öµîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
11) È£Èí±â°è : ¶§¶§·Î ºñÃâÇ÷, õ½Ä, ÀεκÎÁ¾ µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
12) ºñ´¢±â°è : ºó´¢, ¾ß´¢Áõ, Ç÷´¢, ¹ß±âºÎÀü, ÁúÃâÇ÷ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
13) ±âŸ : ¶§¶§·Î ºÎÁ¾ µå¹°°Ô Àü½Å±Çۨ, ¹ßÇÑ, Å»¸ð µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 
 
      
     | 
   
        
  
  
    
   
    | »óÈ£ÀÛ¿ë | 
    1) ´Ù¸¥ ¼Ò¿°ÁøÅëÁ¦¿Í º´¿ëÀº ÇÇÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù.  
2) µð°î½Å Á¦Á¦¿Í º´¿ëÅõ¿©½Ã ±× ÀÛ¿ëÀ» Áõ°½Ãų ¼ö ÀÖÀ¸¹Ç·Î º´¿ëÅõ¿©ÇÏ´Â °æ¿ì¿¡´Â ±× ÀǾàǰÀ»°¨·®ÇÏ´Â µî ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.  
3) ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵åÁ¦¿Í º´¿ëÅõ¿©½Ã »óÈ£ ÀÌ»ó¹ÝÀÀÀÌ Áõ°¡ÇÒ ¼ö ÀÖ´Ù.  
4) ACE ÀúÇØÁ¦ : À̾࿡ ÇÔÀ¯µÈ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦¿¡ ÀÇÇØ ACE ÀúÇØÁ¦ÀÇ Ç×°íÇ÷¾ÐÈ¿°ú°¡ °¨¼ÒµÉ ¼ö ÀÖ´Ù´Â º¸°í°¡ÀÖÀ¸¹Ç·Î ÀÌ ¾à°ú ACE ÀúÇØÁ¦¸¦ º´¿ëÅõ¿©ÇÏ´Â °æ¿ì ÀÌ·¯ÇÑ »óÈ£ÀÛ¿ëÀ» ¿°µÎ¿¡ µÎ¾î¾ß ÇÑ´Ù.  
5) Ǫ·Î¼¼¹Ìµå ¹× Ä¡¾ÆÁþ°è ÀÌ´¢Á¦  
¨ç ÀÓ»ó½ÃÇè ¹× ½ÃÆÇÈÄ Á¶»ç °á°ú ÀÌ ¾à¿¡ ÇÔÀ¯µÈ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦ÀÇ ½ÅÀå¿¡¼ÀÇÇÁ·Î½ºÅ¸±Û¶õµò ÇÕ¼º ¾ïÁ¦¿¡ ÀÇÇØ ÀϺΠȯÀÚ¿¡¼ Ǫ·Î¼¼¹Ìµå ¹× Ä¡¾ÆÁþ°è ÀÌ´¢Á¦ÀÇ ³ªÆ®·ý´¢¹è¼³ È¿°ú°¡ °¨¼ÒÇÒ ¼ö ÀÖÀ½ÀÌ È®ÀεǾú´Ù. ÀÌµé ¾à¹°°ú ÀÌ ¾à¿¡ ÇÔÀ¯µÈ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦¸¦ º´¿ëÅõ¿©ÇÏ´Â µ¿¾È ½ÅºÎÀü ¡Èĸ¦ ¸é¹ÐÈ÷ °üÂûÇØ¾ß ÇÑ´Ù.  
¨è Ǫ·Î¼¼¹Ìµå¿Í º´¿ëÅõ¿©½Ã ±× ÀÛ¿ëÀÌ °¨¼ÒÇÒ ¼ö ÀÖ´Ù.  
6) ¾Æ½ºÇǸ°  
¨ç ¾Æ½ºÇǸ°°úÀÇ º´¿ëÀÌ ÀÌ ¾à¿¡ ÇÔÀ¯µÈ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦ÀÇ »ç¿ë°ú °ü·ÃµÈ Áß´ëÇѽÉÇ÷°ü°è Ç÷Àü¹ÝÀÀÀÇ À§ÇèÀ» °¨¼Ò½Ãų ¼ö ÀÖ´Ù´Â ÀϰüµÈ Áõ°Å´Â ¾ø´Ù. ´Ù¸¥ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦¿Í¸¶Âù°¡Áö·Î ÀÌ ¾à°ú ¾Æ½ºÇǸ°ÀÇ º´¿ë¿¡ ÀÇÇØ ÁßÁõÀÇ À§Àå°ü°è ÀÌ»ó¹ÝÀÀÀÇ ¹ß»ý À§ÇèÀÌ Áõ°¡µÉ ¼ö ÀÖÀ¸¹Ç·Î µÎ ¾à¹°ÀÇ º´¿ëÀº ÀϹÝÀûÀ¸·Î ±ÇÀåµÇÁö ¾Ê´Â´Ù.  
¨è ¾Æ½ºÇǸ°°úÀÇ º´¿ëÅõ¿©½Ã »óÈ£ ±× ÀÛ¿ëÀÌ °¨¼ÒÇÒ ¼ö ÀÖ´Ù.  
7) ¸®Æ¬ : ÀÌ ¾à¿¡ ÇÔÀ¯µÈ ºñ½ºÅ×·ÎÀ̵强¼Ò¿°ÁøÅëÁ¦´Â ½ÅÀå¿¡¼ÀÇ ÇÁ·Î½ºÅ¸±Û¶õµò ÇÕ¼º ¾ïÁ¦¿¡ ÀÇÇØ Ç÷û ¸®Æ¬ÀÇ ³óµµ¸¦ Áõ°¡½ÃŰ°í ½ÅŬ¸®¾î·±½º¸¦ °¨¼Ò½ÃÄÑ ¸®Æ¬ÀÇ ÀÛ¿ëÀ» Áõ°½Ãų ¼ö ÀÖ´Ù. µû¶ó¼ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦¿Í ¸®Æ¬ÀÇ º´¿ëÅõ¿© ½Ã ¸®Æ¬ÀÇ µ¶¼º ¡Èĸ¦ ÁÖÀDZí°Ô °üÂûÇÏ°í°¨·®ÇÏ´Â µî ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.  
8) ¸ÞÅ䯮·º¼¼ÀÌÆ® : ÀÌ ¾à¿¡ ÇÔÀ¯µÈºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦¿ÍÀÇ º´¿ëÅõ¿©·Î ¸ÞÅ䯮·º¼¼ÀÌÆ®ÀÇ µ¶¼ºÀÌ Áõ°¡µÉ ¼ö ÀÖÀ¸¹Ç·Î µÎ ¾à¹°À» º´¿ëÅõ¿©ÇÏ´Â °æ¿ì °¨·®ÇÏ´Â µî ½ÅÁßÈ÷ Åõ¿©ÇÑ´Ù.  
9) Äí¸¶¸°°è Ç×ÀÀÇ÷Á¦(¿ÍÆÄ¸° µî) : À§Àå°ü°è ÃâÇ÷¿¡ ´ëÇÏ¿© Äí¸¶¸°°è Ç×ÀÀÇ÷Á¦¿Í ÀÌ ¾à¿¡ ÇÔÀ¯µÈ ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°ÁøÅëÁ¦´Â »ó½ÂÀÛ¿ëÀ» ³ªÅ¸³¾¼ö ÀÖ´Ù. µÎ ¾àÀ» ÇÔ²² »ç¿ëÇϴ ȯÀÚ´Â ´Üµ¶À¸·Î Åõ¿©ÇÏ´Â °æ¿ì¿¡ ºñÇØ ÁßÁõÀÇ À§Àå°ü°è ÃâÇ÷ÀÇ À§ÇèÀ̳ô¾ÆÁú ¼ö ÀÖÀ¸¹Ç·Î º´¿ëÅõ¿©ÇÏ´Â °æ¿ì Ç÷¾×ÀÀ°í´É °Ë»ç µî °üÂûÀ» ÃæºÐÈ÷ ÇÑ´Ù.  
 
 | 
   
  
    
  
  
       	
  
  
   
    | Off-label Usage | 
    
      
	[Á¶È¸]    
     | 
   
     
  
  
  
  
  
   
    | Related FDA Approved Drug | 
    
      
      ±âÁØ ¼ººÐ: PYRIDOXINE HYDROCHLORIDEBENDECTIN (DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE) 
BEROCCA PN (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN E) 
HEXA-BETALIN (PYRIDOXINE HYDROCHLORIDE) 
INFUVITE ADULT (ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K) 
M.V.C. 9+3 (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I. ADULT (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K) 
M.V.I. ADULT (PHARMACY BULK PACKAGE) (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K) 
M.V.I. PEDIATRIC (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I.-12 (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I.-12 (WITHOUT VITAMIN K) (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
MVC PLUS (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE HYDROCHLORIDE) 
TPN (NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; TYROSINE) 
±âÁØ ¼ººÐ: DICLOFENAC SODIUMARTHROTEC (DICLOFENAC SODIUM; MISOPROSTOL) 
DICLOFENAC SODIUM (DICLOFENAC SODIUM) 
SOLARAZE (DICLOFENAC SODIUM) 
VOLTAREN (DICLOFENAC SODIUM) 
VOLTAREN-XR (DICLOFENAC SODIUM) 
±âÁØ ¼ººÐ: CYANOCOBALAMINBERUBIGEN (CYANOCOBALAMIN) 
BETALIN 12 (CYANOCOBALAMIN) 
CALOMIST (CYANOCOBALAMIN) 
CERNEVIT-12 (ALPHA-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A) 
COBAVITE (CYANOCOBALAMIN) 
CYANOCOBALAMIN (CYANOCOBALAMIN) 
CYANOCOBALAMIN CO 57 SCHILLING TEST KIT (CYANOCOBALAMIN; CYANOCOBALAMIN, CO-57; INTRINSIC FACTOR) 
DEPINAR (CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE) 
DICOPAC KIT (CYANOCOBALAMIN; CYANOCOBALAMIN, CO-57; CYANOCOBALAMIN, CO-58) 
INFUVITE PEDIATRIC (ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K) 
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) (ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K) 
M.V.I.-12 LYOPHILIZED (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE; VITAMIN A; VITAMIN E) 
NASCOBAL (CYANOCOBALAMIN) 
REDISOL (CYANOCOBALAMIN) 
RUBIVITE (CYANOCOBALAMIN) 
RUBRAMIN PC (CYANOCOBALAMIN) 
RUBRATOPE-57 (CYANOCOBALAMIN, CO-57) 
RUBRATOPE-57 KIT (COBALT CHLORIDE, CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN, CO-57; INTRINSIC FACTOR) 
RUBRATOPE-60 (CYANOCOBALAMIN, CO-60) 
RUBRATOPE-60 KIT (COBALT CHLORIDE, CO-60; CYANOCOBALAMIN; CYANOCOBALAMIN, CO-60; INTRINSIC FACTOR) 
RUVITE (CYANOCOBALAMIN) 
VIBISONE (CYANOCOBALAMIN) 
VITAPED (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E) 
VI-TWEL (CYANOCOBALAMIN) 
        
     | 
      
  
  
  |  
     
   
  
    
       |  
      
        
          
            
                | Á¤º¸¿ä¾à |         
             
           
         | 
             	    
       |  
      | 
  
    µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
    
  
  
    
  
   |  
     
   
  
    
       |  
      
        
          
            
                | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |         
             
           
         | 
             	    
       |  
      | 	 |  
     
   
  
    
       |  
      
        
          
            
                | Á¦Ç°Á¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
   
  
    
       |  
      
        
          
            
                | º¹¾àÁ¤º¸ |            
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
   
    | LACTmed ¹Ù·Î°¡±â | 
    
      
        [¹Ù·Î°¡±â]
     | 
     
  
  
   
    | ¾à¸®ÀÛ¿ë | 
    
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
       
     | 
     
  
  
  
   
    | Ãà¾àº¹¾àÁöµµ | 
    
     
    À¯·áÁ¤º¸ÀÔ´Ï´Ù.
    
     | 
   
       
  
  
   
    | º¹¾àÁöµµ | 
    
     
    À¯·áÁ¤º¸ÀÔ´Ï´Ù.
    
     | 
   
                                                          															
  
   
  
  
   
    | ÀӺο¡´ëÇÑÅõ¿© | 
    
      
      
        
	      
	      
	        | *  | 
	        
	          ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù. 
	         | 
	         
	       
	       | 
	   
	  
	    |   | 
	   
	  
	    
	      FDA : Cµî±Þ 
				        
				         (Cyanocobalamin )
				        
	   | 
	  
	  
	  
	     
	     
	     
	     
	     
	     
	   | 
	 
	
	  
	      
	      
	        | *  | 
	        
	          »ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
	         | 
	         
	      
	        | *  | 
	        
	          ¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
	         | 
	         
	       
	   | 
	 
       
     | 
   
  
  
  	   
  
  	   
  
  	   
  
  
  
  
  
  
  
  
   
    | º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸ | 
    
      [º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
     | 
   
  	
  
  
  
   
    | º¹¾à¶óº§ | 
    
    
    
      | À̹ÌÁö | 
      º¹¾à¼³¸í | 
     
    
    
        | 
      º¯ºñ°¡ »ý±æ¼ö ÀÖ½À´Ï´Ù. | 
     
    
       | 
     
    
     |  
    
      
	
	  
            | *  | 
	    º¹¾àÀ̹ÌÁö´Â ¸ðµç º¹¾àÁöµµ »çÇ×À» Ç¥½ÃÇѰÍÀº ¾Æ´Ï¸ç, Ãß°¡ÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ°Å³ª ¼öÁ¤µÉ ¼ö ÀÖ½À´Ï´Ù. | 
	   
	  
            | *  | 
	    º¹¾àÀ̹ÌÁöÀÇ Ç¥½Ã¿©ºÎ´Â ½ÇÁ¦ ¾à¹°º¹¿ë½Ã Á߿䵵¿¡ µû¸¥°ÍÀº ¾Æ´Ï¸ç ´Ü¼øÈ÷ Çã°¡Á¤º¸»ó Ű¿öµå¸¦ ±âÁØÀ¸·Î µî·ÏµÇ¾ú½À´Ï´Ù. | 
	   
	  
            | *  | 
	    ±ÍÇϰ¡ º¹¾àÀ̹ÌÁö Á¤º¸¸¦ ½Å·ÚÇÔÀº ÀüÀûÀ¸·Î ±ÍÇÏÀÇ Ã¥ÀÓÀÔ´Ï´Ù. µå·°ÀÎÆ÷´Â ÀÌ¿¡ ´ëÇÑ ¾î¶°ÇÑ º¸Áõµµ ÇÏÁö ¾Ê½À´Ï´Ù. | 
	   
	   
     |   
     | 
   
  	
  
  
  
   
    | º¸°ü»ó ÁÖÀÇ | 
    
      
    	
     | 
   
  
  
   
    | Á¶Á¦½Ã ÁÖÀÇ | 
    
      
    	
     | 
      
 
 |  
     
   
  
    
       |  
      
        
          
            
                | ½É»çÁ¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
     
  
    
       |  
      
        
          
            
                | ÇмúÁ¤º¸ |          
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
    | DUR (ÀǾàǰ»ç¿ëÆò°¡) | 
    º´¿ë±Ý±â :
     
	 °í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
	 
	  [»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]										
	  ¿¬·É´ë±Ý±â :
      °í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
      
       [¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
       
       
        
        
     | 
   
  
   
    | µ¶¼ºÁ¤º¸ | 
    Cyanocobalamin¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
Pyridoxine¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
  Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do  | 
   
  
   
    | Mechanism of Action | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Vitamin B12 is used in the body in two forms: Methylcobalamin and 5-deoxyadenosyl cobalamin. The enzyme methionine synthase needs methylcobalamin as a cofactor. This enzyme is involved in the conversion of the amino acid homocysteine into methionine. Methionine in turn is required for DNA methylation. 5-Deoxyadenosyl cobalamin is a cofactor needed by the enzyme that converts L-methylmalonyl-CoA to succinyl-CoA. This conversion is an important step in the extraction of energy from proteins and fats. Furthermore, succinyl CoA is necessary for the production of hemoglobin, the substances that carries oxygen in red blood cells.
  Diclofenac¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of ketoprofen. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.
  Pyridoxine¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Vitamin B6 is the collective term for a group of three related compounds, pyridoxine (PN), pyridoxal (PL) and pyridoxamine (PM), and their phosphorylated derivatives, pyridoxine 5'-phosphate (PNP), pyridoxal 5'-phosphate (PLP) and pyridoxamine 5'-phosphate (PMP). Although all six of these compounds should technically be referred to as vitamin B6, the term vitamin B6 is commonly used interchangeably with just one of them, pyridoxine. Vitamin B6, principally in the form of the coenzyme pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA).
  Thiamine¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ It is thought that the mechanism of action of thiamine on endothelial cells is related to a reduction in intracellular protein glycation by redirecting the glycolytic flux. 
     | 
   
  
   
    | Pharmacology | 
     
       Cyanocobalamin¿¡ ´ëÇÑ Pharmacology Á¤º¸ Cyanocobalamin (Vitamin B12) is a water-soluble organometallic compound with a trivalent cobalt ion bound inside a corrin ring. It is needed for nerve cells and red blood cells, and to make DNA. Vitamin B12 deficiency is the cause of several forms of anemia.
  Diclofenac¿¡ ´ëÇÑ Pharmacology Á¤º¸ Diclofenac is an acetic acid nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties. Diclofenac is used to treat pain, dysmenorrhea, ocular inflammation, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and actinic keratosis
  Pyridoxine¿¡ ´ëÇÑ Pharmacology Á¤º¸ Vitamin B6 (pyridoxine) is a water-soluble vitamin used in the prophylaxis and treatment of vitamin B6 deficiency and peripheral neuropathy in those receiving isoniazid (isonicotinic acid hydrazide, INH). Vitamin B6 has been found to lower systolic and diastolic blood pressure in a small group of subjects with essential hypertension. Hypertension is another risk factor for atherosclerosis and coronary heart disease. Another study showed pyridoxine hydrochloride to inhibit ADP- or epinephrine-induced platelet aggregation and to lower total cholesterol levels and increase HDL-cholesterol levels, again in a small group of subjects. Vitamin B6, in the form of pyridoxal 5'-phosphate, was found to protect vascular endothelial cells in culture from injury by activated platelets. Endothelial injury and dysfunction are critical initiating events in the pathogenesis of atherosclerosis. Human studies have demonstrated that vitamin B6 deficiency affects cellular and humoral responses of the immune system. Vitamin B6 deficiency results in altered lymphocyte differentiation and maturation, reduced delayed-type hypersensitivity (DTH) responses, impaired antibody production, decreased lymphocyte proliferation and decreased interleukin (IL)-2 production, among other immunologic activities.
  Thiamine¿¡ ´ëÇÑ Pharmacology Á¤º¸ Thiamine is a vitamin with antioxidant, erythropoietic, cognition-and mood-modulatory, antiatherosclerotic, putative ergogenic, and detoxification activities. Thiamine has been found to protect against lead-induced lipid peroxidation in rat liver and kidney. Thiamine deficiency results in selective neuronal death in animal models. The neuronal death is associated with increased free radical production, suggesting that oxidative stress may play an important early role in brain damage associated with thiamine deficiency. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. Inhibition of endothelial cell proliferation may also promote atherosclerosis. Endothelial cells in culture have been found to have a decreased proliferative rate and delayed migration in response to hyperglycemic conditions. Thiamine has been shown to inhibit this effect of glucose on endothelial cells. 
     | 
   
  
   
    | Metabolism | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Methylenetetrahydrofolate reductase
  Diclofenac¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Cytochrome P450 2C9 (CYP2C9)Cytochrome P450 2C19 (CYP2C19)Cytochrome P450 1A2 (CYP1A2)Cytochrome P450 2C8 (CYP2C8)Cytochrome P450 2D6 (CYP2D6)Glucuronosyltransferase
  Pyridoxine¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Methylenetetrahydrofolate reductase 
     | 
   
  
   
    | Protein Binding | 
    
       Cyanocobalamin¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ Very high (to specific plasma proteins called transcobalamins); binding of hydroxocobalamin is slightly higher than cyanocobalamin.
  Diclofenac¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ More than 99%
  Pyridoxine¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ 22%
  Thiamine¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ 90-94% 
     | 
   
  
   
    | Half-life | 
    
       Cyanocobalamin¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ Approximately 6 days (400 days in the liver).
  Diclofenac¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ 2 hours
  Pyridoxine¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ 15-20 days 
     | 
   
  
   
    | Absorption | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Absorption Á¤º¸ Readily absorbed in the lower half of the ileum.
  Diclofenac¿¡ ´ëÇÑ Absorption Á¤º¸ Completely absorbed from the gastrointestinal tract.
  Pyridoxine¿¡ ´ëÇÑ Absorption Á¤º¸ The B vitamins are readily absorbed from the gastrointestinal tract, except in malabsorption syndromes. Pyridoxine is absorbed mainly in the jejunum.
  Thiamine¿¡ ´ëÇÑ Absorption Á¤º¸ Absorbed mainly from duodenum, by both active and passive processes 
     | 
   
  
   
    | Biotransformation | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic
  Diclofenac¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic
  Thiamine¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic 
     | 
   
  
   
    | Toxicity | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Toxicity Á¤º¸ Anaphylactic reaction (skin rash, itching, wheezing)-after parenteral administration. ORL-MUS LD50 > 8000 mg/kg
  Diclofenac¿¡ ´ëÇÑ Toxicity Á¤º¸ Symptoms of overdose include loss of consciousness, increased intracranial pressure, and aspiration pneumonitis. LD50=390mg/kg (orally in mice)
  Pyridoxine¿¡ ´ëÇÑ Toxicity Á¤º¸ Oral Rat LD50 = 4 gm/kg. Toxic effects include convulsions, dyspnea, hypermotility, diarrhea, ataxia and muscle weakness.
  Thiamine¿¡ ´ëÇÑ Toxicity Á¤º¸ Thiamine toxicity is uncommon; as excesses are readily excreted, although long-term supplementation of amounts larger than 3 gram have been known to cause toxicity. Oral mouse LD50 = 8224 mg/kg, oral rat LD50 = 3710 mg/kg. 
     | 
   
  
   
    | Drug Interactions | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available
  Diclofenac¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Alendronate	Increased risk of gastric toxicityAnisindione	The NSAID increases the anticoagulant effectCyclosporine	Monitor for nephrotoxicityDicumarol	The NSAID increases the anticoagulant effectWarfarin	The NSAID increases the anticoagulant effectRifampin	Decreased levels/effect of the NSAID
  Pyridoxine¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available
  Thiamine¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available 
     | 
   
  
   
    CYP450  Drug Interaction | 
    
      [CYP450 TableÁ÷Á¢Á¶È¸] Diclofenac¿¡ ´ëÇÑ P450 table
  SUBSTRATES 
CYP 2C9 
NSAIDs: 
**diclofenac** 
ibuprofen 
piroxicam 
Oral Hypoglycemic Agents: 
tolbutamide 
glipizide 
Angiotensin II Blockers: 
NOT candesartan 
irbesartan 
losartan 
NOT valsartan 
celecoxib 
fluvastatin naproxen 
phenytoin 
sulfamethoxazole 
tamoxifen 
tolbutamide 
torsemide 
warfarin 
 INHIBITORS 
CYP 2C9 
amiodarone 
fluconazole 
isoniazid 
 INDUCERS 
CYP 2C9 
rifampin 
secobarbital 
 
     | 
   
  
   
    | Food Interaction | 
    
       Diclofenac¿¡ ´ëÇÑ Food Interaction Á¤º¸ Take with food to reduce irritation.Avoid alcohol. 
     | 
   
  
   
    | Drug Target | 
    
      
      [Drug Target]
     | 
   
  
   
    | Description | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Description Á¤º¸ Cyanocobalamin (commonly known as Vitamin B12) is the most chemically complex of all the vitamins. Cyanocobalamin's structure is based on a corrin ring, which, although similar to the porphyrin ring found in heme, chlorophyll, and cytochrome, has two of the pyrrole rings directly bonded. The central metal ion is Co (cobalt). Cyanocobalamin cannot be made by plants or by animals, as the only type of organisms that have the enzymes required for the synthesis of cyanocobalamin are bacteria and archaea. Higher plants do not concentrate cyanocobalamin from the soil and so are a poor source of the substance as compared with animal tissues. Cyanocobalamin is naturally found in foods including meat (especially liver and shellfish), eggs, and milk products. [HMDB]
  Diclofenac¿¡ ´ëÇÑ Description Á¤º¸ A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. [PubChem]
  Pyridoxine¿¡ ´ëÇÑ Description Á¤º¸ The 4-methanol form of vitamin B 6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.  Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). [PubChem]
  Thiamine¿¡ ´ëÇÑ Description Á¤º¸ 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride. [PubChem] 
     | 
   
  
   
    | Dosage Form | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Capsule	OralLiquid	IntramuscularLiquid	OralPowder	OralSolution	IntramuscularTablet	OralTablet, extended release	Oral
  Diclofenac¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Solution	OphthalmicSolution	TopicalSuppository	RectalTablet	OralTablet, coated	OralTablet, extended release	Oral
  Pyridoxine¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Liquid	IntramuscularSolution	IntramuscularSolution / drops	OralTablet	Oral
  Thiamine¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Liquid	IntramuscularLiquid	IntravenousSolution	IntravenousTablet	Oral 
     | 
   
  
   
    | Drug Category | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Drug_Category Á¤º¸ Antianemic AgentsEssential VitaminVitamins (Vitamin B Complex)
  Diclofenac¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsNonsteroidal Antiinflammatory Agents (NSAIDs)
  Pyridoxine¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-inflammatory AgentsEssential VitaminVitamin B ComplexVitamins (Vitamin B Complex)
  Thiamine¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-inflammatory AgentsEssential VitaminVitamin B ComplexVitamins (Vitamin B Complex) 
     | 
   
  
   
    | Smiles String Canonical | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ [Co+3].[C-]
  Diclofenac¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
  Pyridoxine¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC1=NC=C(CO)C(CO)=C1O
  Thiamine¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC1=NC=C(C[N+]2=CSC(CCO)=C2C)C(N)=N1 
     | 
   
  
   
    | Smiles String Isomeric | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ [Co+3].[C-]
  Diclofenac¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
  Pyridoxine¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CC1=NC=C(CO)C(CO)=C1O
  Thiamine¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CC1=NC=C(C[N+]2=CSC(CCO)=C2C)C(N)=N1 
     | 
   
  
   
    | InChI Identifier | 
    
       Cyanocobalamin¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;-1;+3/p-1/t31?,34-,35-,36-,37+,41+,52?,53?,56?,57+,59-,60+,61+,62+;;/m1../s1/fC62H89N13O14P.CN.Co/h69,85H,63-68H2;;/q-1;2m/b42-23-,54-32-,55-33-;;
  Diclofenac¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)/f/h18H
  Pyridoxine¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3
  Thiamine¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1/f/h13H2 
     | 
   
  
   
    | Chemical IUPAC Name | 
    
       Cyanocobalamin¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ Not Available
  Diclofenac¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetic acid
  Pyridoxine¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
  Thiamine¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol 
     | 
   
  
   
    | Drug-Induced Toxicity Related Proteins | 
    
      DICLOFENAC ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:CYP3A4 Drug:Diclofenac Toxicity:idiosyncratic hepatotoxicity.  [¹Ù·Î°¡±â] Replated Protein:CYP2C9 Drug:Diclofenac Toxicity:idiosyncratic hepatotoxicity.  [¹Ù·Î°¡±â] 
     | 
   
    
  |  
     
     
  
    
       |  
      
        
          
            
                | »ç¿ëÀÚÄÁÅÙÃ÷ |           
             
           
         | 
             	  
       |  
       |  
     
         
 
     | 
   
   
     | 
   
  
    
      
        
          
            
              - 
                ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2021-12-09
              
 
              - 
                
                 º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
                
              
     
             
         |                 
       
     |       
          
                
                    
                       ¾Ë¸² | 
                       
                      »ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.  | 
                    
                    | 
               
      
      
                
                    
                       °æ°í | 
                     
                      µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. 
                          Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â 
                          Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
                            ¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
                          ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
 | 
  
                    | 
               
  
 
  
    ¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é 
    ¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
   
  The database contains the following fields: The generic name of each chemical For module A10 (liver enzyme composite module): Overall activity category for each compound (A for active, M for marginally active, or I for inactive) based on the number of active and marginally active scores for each compound at the five individual endpoints (see research article for full description of method) Number of endpoints at which each compound is marginally active (M) Number of endpoints at which each compound is active (A) For modules A11 to A15 (alkaline phosphatase increased, SGOT increased, SGPT increased, LDH increased, and GGT increased, respectively): Overall activity category for each compound (A for active, M for marginally active, or I for inactive) based on the RI and ADR values (see the research article for full description of method) Number of ADR reports for each compound, given as <4 or ¡Ã4 Reporting Index value for each compound, except where no shipping units were available (NSU) Group 1 comprises of compounds for which ADR data were available for the first five years of marketing, so when no ADR reports were listed during this period the compounds were evaluated as inactive. Group 2 comprises of compounds for which a 'steady state' period of ADR data were available (1992-1996). In cases where no ADR reports were filed during this period, the compounds were scored as 'NA' (data not available) since they may have had one or more ADR reports during their first five years of marketing which should not be negated by a lack of ADR reports during the steady-state period. DICLOFENAC[GGT Increase][Composite Activity](Score)  A(Marginal)  1(Active)  3[Alkaline Phosphatase Increase](Activity Score)  A(Number of Rpts)  ¡Ã4(Index value)  9.2[SGOT Increase](Activity Score)  A(Number of Rpts)  ¡Ã4(Index value)  11.4[SGPT Increase](Activity Score)  A(Number of Rpts)  ¡Ã4(Index value)  11.1[LDH Increase](Activity Score)  I(Number of Rpts)  ¡Ã4(Index value)  2[GGT Increase](Activity Score)  M(Number of Rpts)  ¡Ã4(Index value)  3.8
 
  º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
 
  [ÀǾàǰº´¿ë/¿¬·É´ë±Ý±â °í½Ã±Ù°Å·Î ¹Ù·Î°¡±â]       Á¦¸ñ ¾øÀ½ 
 
    
    2008³â 8¿ù 1ÀÏ ¾à°¡ÈÀÏ»ó 8¿ù´Þ ½Å±ÔµîÀç ¹× »èÁ¦µÇ´Â ǰ¸ñ Æ÷ÇÔÇÑ º´¿ë¿¬·É ±Ý±â ǰ¸ñ¸®½ºÆ® ±âÁØ
    
    1. ÇöÀç °Ë»öÇÑ Á¦Ç°¿¡ ´ëÇÑ  º´¿ë±Ý±â Á¦Ç° Á¸Àç¿©ºÎ ¹× °Ë»ö
    ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 Á¦Ç°³»¿ª °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
          
    
    
    
    2. ¿¬·É´ë±Ý±â Á¸Àç¿©ºÎ
    ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ ¿¬·É±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
 
 
 
   
  |  
                           
                         |